Bard buys Californian bulking agent firm Genyx:
This article was originally published in Clinica
CR Bard has agreed to buy Genyx Medical, a private firm based in Aliso Viejo, California, that makes and markets an alternative treatment to surgery for stress urinary incontinence. For an undisclosed sum, it has acquired the assets related to Uryx, a CE marked bulking agent that is injected into the area surrounding the female urethra to support the urinary sphincter. The product is in late-stage trials in the US and Genyx expects to file for pre-market approval in the first half of this year. Bard already markets a collagen implant, Contigen, to treat the condition.